Related Experiment Video
Updated: Jun 27, 2026
09:52
An Implantable System For Chronic In Vivo Electromyography
Published on: April 21, 2020
Ice-pack test in myasthenia gravis: electrophysiological basis
Z Odabasi1, J A Brooks, D S Kim
1From the Department of Neurology, University of Alabama at Birmingham, Veterans Affairs Medical Center, Birmingham, AL.
Journal of Clinical Neuromuscular Disease
|December 17, 2008
Summary
The ice-pack test and repetitive nerve stimulation (RNS) test were combined in myasthenia gravis patients. Both tests demonstrated clinical and electrophysiological improvements, suggesting the ice-pack test aids myasthenia gravis diagnosis.
Area of Science:
- Neurology
- Clinical Electrophysiology
Background:
- Myasthenia gravis is a neuromuscular disorder characterized by fluctuating muscle weakness.
- Diagnostic challenges in myasthenia gravis can be addressed by novel testing methods.
Purpose of the Study:
- To investigate the combined efficacy of the ice-pack test and repetitive nerve stimulation (RNS) in diagnosing myasthenia gravis.
- To evaluate the clinical and electrophysiological effects of the ice-pack test in myasthenia gravis patients.
Main Methods:
- Three myasthenia gravis patients underwent both the ice-pack test and RNS testing.
- Ptosis improvement was assessed clinically after ice application.
- Facial nerve RNS was performed to evaluate decremental response.
Main Results:
- All patients exhibited significant ptosis improvement on the side where the ice pack was applied.
- RNS testing showed a marked improvement in the decremental response.
- The ice-pack test correlated with electrophysiological findings.
Conclusions:
- The ice-pack test provides both clinical and electrophysiological benefits in myasthenia gravis.
- Combining the ice-pack test with RNS may enhance diagnostic accuracy for myasthenia gravis.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...